LianBioNASDAQ:LIAN
- LAST PRICE1.6700
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots1.6100/ 8
- Ask / Lots1.7500/ 99
- Open / Previous Close0.0000 / 1.6700
- Day Range---
- 52 Week Range
- Volume100
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LIAN |
|---|---|---|
| 09:32 ET | 1501 | 1.74 |
| 09:36 ET | 200 | 1.695 |
| 09:39 ET | 600 | 1.71 |
| 09:43 ET | 100 | 1.73 |
| 09:45 ET | 2145 | 1.67 |
| 09:48 ET | 1100 | 1.67 |
| 09:52 ET | 1700 | 1.69 |
| 09:54 ET | 600 | 1.67 |
| 09:56 ET | 100 | 1.68 |
| 09:59 ET | 500 | 1.68 |
| 10:08 ET | 576 | 1.6768 |
| 10:17 ET | 100 | 1.7 |
| 10:32 ET | 349 | 1.6948 |
| 10:37 ET | 283 | 1.67 |
| 10:48 ET | 300 | 1.67 |
| 11:04 ET | 400 | 1.65 |
| 11:22 ET | 8300 | 1.6201 |
| 11:36 ET | 100 | 1.66 |
| 11:40 ET | 200 | 1.6585 |
| 12:25 ET | 760 | 1.65 |
| 12:30 ET | 100 | 1.64 |
| 12:34 ET | 300 | 1.67 |
| 01:24 ET | 3049 | 1.63 |
| 01:26 ET | 500 | 1.62 |
| 01:28 ET | 500 | 1.63 |
| 01:35 ET | 200 | 1.6399 |
| 01:44 ET | 1400 | 1.62 |
| 01:48 ET | 600 | 1.63 |
| 01:55 ET | 1600 | 1.63 |
| 01:57 ET | 200 | 1.63 |
| 02:09 ET | 900 | 1.63 |
| 02:20 ET | 750 | 1.6299 |
| 02:45 ET | 1300 | 1.64 |
| 02:49 ET | 100 | 1.64 |
| 02:51 ET | 600 | 1.6399 |
| 03:02 ET | 450 | 1.6545 |
| 03:21 ET | 100 | 1.65 |
| 03:39 ET | 300 | 1.65 |
| 03:52 ET | 1550 | 1.64 |
| 03:56 ET | 1000 | 1.65 |
| 03:57 ET | 1204 | 1.63 |
| 03:59 ET | 3400 | 1.67 |
Yesterday
BRIEF-LianBio Reports Q4 Loss Per Share Of $0.17, from 23 hours ago by Thomson Reuters
23 hours ago by Thomson ReutersLianBio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update, from 23 hours ago by GlobeNewswire
23 hours ago by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LianBio | 181.0M | -1.6x | --- |
Rallybio Corp | 179.0M | -2.2x | --- |
Greenwich Lifesciences Inc | 177.7M | -24.4x | --- |
Nuvectis Pharma Inc | 176.7M | -8.1x | --- |
Tenaya Therapeutics Inc | 176.5M | -0.9x | --- |
AN2 Therapeutics Inc | 187.6M | 0.0x | --- |
Company Information
LianBio is a biopharmaceutical company. The Company is focused on developing and commercializing medicines for patients with unmet medical needs, with a focus on in-licensing assets for Greater China and other Asian markets. It offers a pipeline of nine product candidates across five therapeutic areas, namely cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. Its product candidates include Mavacamten, TP-03, NBTXR3, Infigratinib, BBP-398, Omilancor, NX-13, LYR-210 and Sisunatovir. Mavacamten is an oral small-molecule allosteric modulator of cardiac myosin, which is being studied for the treatment of hypertrophic cardiomyopathy (HCM) and has potential therapeutic applications for other diseases of diastolic dysfunction. TP-03 is a topical ophthalmic formulation of lotilaner, that is used for the treatment of demodex blepharitis and meibomian gland disease. NBTXR3 is a radio enhancer for the treatment of head and neck cancer and other solid tumors.
Contact Information
- Headquarters
- 103 Carnegie Center Drive Suite 309, Suite 215PRINCETON, NJ, United States 08540
- Phone
- 609-486-2308
- Fax
- ---
Executives
- Executive Chairman of the Board
- Konstantin Poukalov
- Chief Executive Officer, Director
- Yizhe Wang
- Chief Financial Officer
- Yi Larson
- China General Manager
- Pascal Qian
- Chief Business Officer
- Brianne Jahn
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $181.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 108.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.05 |
Book Value | $3.30 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
